XENETIC BIOSCIENCES, INC. (XBIO) Net income 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$2.7MFY2025 · since FY2016: -$54.2M → -$2.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.7M | +32.3% |
| FY2024 | -$4.0M | +4.2% |
| FY2023 | -$4.1M | +36.9% |
| FY2022 | -$6.6M | -16.1% |
| FY2021 | -$5.6M | +48.2% |
| FY2020 | -$10.9M | +14.7% |
| FY2019 | -$12.8M | -75.0% |
| FY2018 | -$7.3M | -103.1% |
| FY2017 | -$3.6M | +93.4% |
| FY2016 | -$54.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIO financial trends
XBIO RevenueXBIO Net marginXBIO Gross profitXBIO Gross marginXBIO Operating incomeXBIO Operating marginXBIO Operating cash flowXBIO Free cash flowXBIO Capital expendituresXBIO Return on equityXBIO Stock buybacksXBIO Dividends paidXBIO Total assetsXBIO Total liabilitiesXBIO Shareholders’ equityXBIO overview →